Evaluation of antibiotic sensitivity of microorganisms, which were isolated from patients with acute pyelonephritis in the stage of purulent inflammation and located inside red blood cells (in vitro experiment)


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Aim. To study the antibiotic sensitivity of strains of microorganisms isolated from patients with a purulent stage of acute pyelonephritis and located inside the erythrocytes. Materials and methods. In this study, a total of 15 strains of microorganisms isolated from the blood of patients with a purulent form of acute pyelonephritis were used. The bacteria were detected and identified in the blood of patients using a modern molecular genetic method, fluorescent in situ hybridization (FISH), and the classical bacteriological study was done to isolate blood cultures of microorganisms. When studying the effect of antibiotics on the microorganism strains located inside red blood cells, the method of staged lysis was used. Results. It was found that microorganisms isolated from patients with a purulent stage of acute pyelonephritis and, subsequently, inside red blood cells (in vitro experiment) in 80% of cases were resistant to antibacterial drugs of different groups (fluoroquinolones, aminoglycosides, macrolides, phosphonic acid derivatives). Outside of red blood cells, the same pathogens were sensitive to the antibiotics used in the work. Apparently, it is possible to consider the resistance to antibiotics of uropathogens located inside red blood cells as a result of insufficient intracellular concentration of the drug even when it is delivered by the method of stepwise lysis. Conclusion. When treating patients with acute pyelonephritis in the stage of purulent inflammation, it is necessary to consider that microorganisms can penetrate into red blood cells. In vitro experiments have shown that microorganisms inside red blood cells exhibit antibiotic resistance to antibacterial drugs of different groups. It is necessary to further study the intraerythrocytic microorganisms in the purulent stage of acute pyelonephritis, as a new pathogenesis mechanism of its development. Perhaps, these results can result in revision of the principles of antibiotic therapy.

Full Text

Restricted Access

About the authors

E. A Shchuplova

Institute of Cellular and Intracellular Symbiosis, Ural Branch of the RAS

Email: khanina83@yandex.ru
Ph.D., senior researcher Orenburg, Russia

M. D Kuzmin

Institute of Cellular and Intracellular Symbiosis, Ural Branch of the RAS

Email: mdk-49@mail.ru
Ph.D., MD, Leading Researcher of the Institute of Cellular and Intracellular Symbiosis of the Ural Branch of the Russian Academy of Sciences, a separate structural subdivision of the OFIC Ural Branch of the Russian Academy of Sciences; urologist of the highest qualification category, honored doctor of the Russian Federation and the Republic of Mordovia Orenburg, Russia

References

  1. Perepanova T.S., Kozlov Z.S., Dekhnich A.V. The choice of antibacterial drugs for urinary infection. Urologiya. 2012;2:4-8. @@Перепанова Т.С., Козлов З.С., Дехнич А.В. Выбор антибактериальных препаратов при мочевой инфекции. Урология. 2012;2:4-8.
  2. Leung AKC, Wong AHC, Leung AAM, Hon K.L. Urinary Tract Infection in Children. Recent Pat Inflamm Allergy Drug Discov. 2019;13(1):2-18. Doi: 10. 2174/1872213X13666181228154940.
  3. Eisenreich W., Rudel T, Heesemann J., Goebel W. Persistence of intracellular bacterial pathogens-with a focus on the metabolic perspective//Front Cell Infect Microbiol. 2021;10:615450. doi: 10.3389/fcimb.2020.615450
  4. Sinyakova LA. Antibacterial therapy of acute pyelonephritis.Russkij medicinskij zhurnal. 2004; 11 (18): 1002-1006. @@Синякова Л.А. Антибактериальная терапия острого пиелонефрита. Русский медицинский журнал. 2004;11(18):1002-1006.
  5. Bader M.S., Loeb M., Leto D., Brooks A.A. Treatment ofurinary tract infections in the era of antimicrobial resistance and new antimicrobial agents. Postgrad Med. 2020;132(3):234-250. doi: 10.1080/00325481.2019.1680052.
  6. Sinyakova L.A. Purulent pyelonephritis (modern diagnosis and treatment): dis.. d-ra med. nauk. M., 2002. (Синякова Л.А. Гнойный пиелонефрит (современная диагностика и лечение): дигс. д-ра мед. наук. М., 2002).
  7. Sinyakova L.A. Antibacterial therapy of acute pyelonephritis. Effektivnaya farmakoterapiya. 2016;11:34-39. @@Синякова Л.А. Антибактериальная терапия острого пиелонефрита. Эффективная фармакотерапия. 2016;11:34-39.
  8. Vitry M.A, Hanot Mambres D., Deghelt M., Hack K., Machelart A., Lhomme F., et al. Brucella melitensis invades murine erythrocytes during infection. Infect Immun. 2014; 82: 3927-3938.
  9. Yamaguchi M., Terao Y., Mori-Yamaguchi Y., Domon H., Sakaue Y., Yagi T., et al. Streptococcus pneumoniae invades erythrocytes and utilizes them to evade human innate immunity. PLoS One. 2013; 8: e77282.
  10. Shchuplova E.A., Stadnikov AA., Fadeev S.B. Rol’ biologicheskih svojstv Staphylococcus epidermidis vo vnutriehritrocitarnoj invazii i izmenenii aktivnosti katalazy i superoksiddismutazy ehritrocitov pri ehksperimental’noj generalizovannoj infekcii. Byulleten’ ehksperimental’noj biologii i mediciny. 2015;159(1):79-82 @@Щуплова Е.А., Стадников А.А., Фадеев С.Б. Роль биологических свойств Staphylococcus epidermidis во внутриэритроцитарной инвазии и изменении активности каталазы и супероксиддисмутазы эритроцитов при экспериментальной генерализованной инфекции. Бюллетень экспериментальной биологии и медицины. 2015;159(1):79-82.
  11. Shchuplova E.A., Kuz'min M.D. The additional criterion for the diagnosis of purulent-destructive forms of acute pyelonephritis. Urologiia. 2019;2:5-8. @@Щуплова Е.А., Кузьмин М.Д. Дополнительный критерий в диагностике гнойно-деструктивной формы острого пиелонефрита. Урология. 2019;2:5-8.
  12. Buharin O.V., Usvyacov B.YA., Shchuplova E.A. Antigemoglobinovaya aktivnost’ bakterij pri vzaimodejstvii s eritrocitami i ee rol’ v patogeneze anemii pri infekcii. Gematologiya i transfuziologiya. 2011;56(1):3-6. @@Бухарин О.В., Усвяцов Б.Я., Щуплова Е.А. Антигемоглобиновая активность бактерий при взаимодействии с эритроцитами и ее роль в патогенезе анемии при инфекции. Гематология и трансфузиология. 2011;56(1):3-6.
  13. Sarbash V.I. i dr. Erythrocytes - carriers of drugs. Rossijskij himicheskij zhurnal. 2007; LI(1):143-149. @@Сарбаш В.И. и др. Эритроциты - носители лекарственных препаратов. Российский химический журнал. 2007; LI(1):143-149.
  14. Gavrilov S.N., Skachkova T.S., Shipulina O.Yu., Savochkina Yu.A., Shipulin G.A., Maleev V.V. Modern molecular genetic methods used for etiological diagnosis of sepsis. Zhurnal mikrobiologii, ehpidemiologii i immunobiologii. 2016;2:91-99. @@Гаврилов С.Н., Скачкова Т.С., Шипулина О.Ю., Савочкина Ю.А., Шипулин Г.А., Малеев В.В. Современные молекулярно-генетические методы, используемые для этиологической диагностики сепсиса. Журнал микробиологии, эпидемиологии и иммунобиологии. 2016;2:: 91-99.
  15. Leung AKC, Wong AHC, Leung AAM, Hon KL. Urinary Tract Infection in Children. Recent Pat Inflamm Allergy Drug Discov. 2019;13(1):2-18. Doi: 10. 2174/1872213X13666181228154940.
  16. Gostev V.V, Sopova YU.V., Kalinogorskaya O.S., Velizhanina M.E. i dr. The effect of shock concentrations of vancomycin on the formation of heteroresistance in Staphylococcus aureus. Antibiotiki i himioterapiya. 2020;65(9-10):3-7. @@Гостев В.В., Сопова Ю.В., Калиногорская О.С., Велижанина М.Е. и др. Влияние шоковых концентраций ванкомицина на формирование гетерорезистентности у Staphylococcus aureus. Антибиотики и химиотерапия. 2020;65(9-10):3-7.
  17. Rafalskiy V.V., Dovgan E.V. Resistance of urinary tract pathogens and the choice of antimicrobial therapy: deceptive simplicity. Urologiia. 2017:3: 104-110. @@Рафальский В.В., Довгань Е.В. Резистентность возбудителей инфекций мочевыводящих путей и выбор антимикробной терапии: обманчивая простота. Урология. 2017:3:104-110.
  18. Antimicrobial therapy and prevention of infections of the kidneys, urinary tract and male genital organs. Federal Clinical Recommendations, Moscow, 2020. @@Антимикробная терапия и профилактика инфекций почек, мочевыводящих путей и мужских половых органов. Федеральные клинические рекомендации, Москва, 2020.
  19. Institute Carls. Performance frendards for Antimicrobial susceptibility testing; Twenty-Fourth (informational supplement (M100-S24)), lu; 2014:230

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2021 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies